Merck acquires cancer therapy developer Modifi Biosciences Ruchika Sharma31 Oct 2024 11:00 AM ISTNew Haven: Modifi Biosciences, Inc., has announced that the company has been acquired by Merck, known as MSD outside of the United States...
MSD Phase 3 trial of head and neck cancer treatment meets primary endpoint Ruchika Sharma13 Oct 2024 10:00 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the Phase 3 KEYNOTE-689 trial evaluating KEYTRUDA...
Merck gets positive EU CHMP opinions for Keytruda regimens for patients with two types of Gynecologic cancers Ruchika Sharma24 Sept 2024 10:00 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Medicines Agency's Committee for Medicinal...
USFDA nod to Merck KEYTRUDA plus Pemetrexed, Platinum Chemotherapy for Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma Ruchika Sharma23 Sept 2024 7:26 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S.Food and Drug Administration (FDA) has approved KEYTRUDA,...
Merck, EyeBio announce initiation of Phase 2b/3 clinical trial for Restoret for Diabetic Macular Edema Ruchika Sharma8 Sept 2024 4:00 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, and EyeBio, a wholly-owned subsidiary of Merck & Co., Inc., Rahway,...
Merck discontinues Phase 3 trial for lung cancer combo drug Ruchika Sharma11 Aug 2024 10:00 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the discontinuation of the Phase 3 KeyVibe-008 trial based on...
Merck completes acquisition of EyeBio Ruchika Sharma14 July 2024 10:00 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the completion of the acquisition of Eyebiotech Limited...
Merck Animal Health concludes acquisition of Elanco Aqua business Ruchika Sharma12 July 2024 2:44 PM ISTRahway: Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway,...
Merck discontinues Phase 3 trial of Xevinapant in locally advanced head and neck cancer Ruchika Sharma27 Jun 2024 5:04 PM ISTGermany: Merck, a science and technology company, has announced the discontinuation of the Phase III randomized TrilynX study evaluating...
Merck Capvaxive gets USFDA nod for prevention of Invasive Pneumococcal Disease, Pneumococcal Pneumonia in adults Ruchika Sharma18 Jun 2024 2:04 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has approved...
USFDA approves Merck Keytruda plus Carboplatin, Paclitaxel for Primary Advanced or Recurrent Endometrial Carcinoma Ruchika Sharma18 Jun 2024 11:30 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has approved...
Focused on second- and third-generation opportunities in cardiometabolic drugs market: Merck Ruchika Sharma12 Jun 2024 1:46 PM ISTMerck emphasized its focus on second- and third-generation opportunities within the cardiometabolic drugs market, including weight-loss therapies, the...
